刘, 淑. (2025). Prediction of Therapeutic Effect of Perinuclear Antineutrophil Cytoplasmic Antibody on Vederizumab in the Treatment of Ulcerative Colitis. Advances in clinical medicine, 15(2), 2033-2040. https://doi.org/10.12677/acm.2025.152566
Chicago Style (17th ed.) Citation刘, 淑娴. "Prediction of Therapeutic Effect of Perinuclear Antineutrophil Cytoplasmic Antibody on Vederizumab in the Treatment of Ulcerative Colitis." Advances in Clinical Medicine 15, no. 2 (2025): 2033-2040. https://doi.org/10.12677/acm.2025.152566.
MLA (9th ed.) Citation刘, 淑娴. "Prediction of Therapeutic Effect of Perinuclear Antineutrophil Cytoplasmic Antibody on Vederizumab in the Treatment of Ulcerative Colitis." Advances in Clinical Medicine, vol. 15, no. 2, 2025, pp. 2033-2040, https://doi.org/10.12677/acm.2025.152566.